Why the Six Allergens in Amuse Cover More Than You Think

Amuse introduces peanut, walnut, cashew, milk, egg, and sesame — but the science of cross-reactivity means those six ingredients represent a much broader protein landscape than six individual foods alone.
Table of Contents
    Add a header to begin generating the table of contents

    When parents look at the Amuse formula — peanut, walnut, cashew, milk, egg, and sesame — the natural question is: why these six? The answer has two parts. The first is that these are the most common food allergens in early childhood, accounting for the vast majority of allergic reactions in infants and toddlers. The second part is less obvious, and it matters: because of how proteins are shared across botanical families, introducing these six foods actually exposes your baby to the protein families behind a much wider group of allergens.

    This is the science of cross-reactivity. And understanding it makes the case for Amuse’s formula even stronger than the ingredient list suggests.

    64–100%
    co-allergy rate between cashew and pistachio
    NUT CRACKER Study, 2018
    81%
    reduction in peanut allergy with early introduction
    LEAP Study, Du Toit et al., NEJM 2015
    1 in 13
    children in the U.S. have a food allergy
    Gupta et al., Pediatrics 2018

    What is cross-reactivity, and why does it matter?

    Cross-reactivity happens when proteins from two different foods are structurally similar enough that the immune system responds to both. This is determined largely by botanical family — cashew and pistachio, for instance, are both members of the Anacardiaceae family and share several of the same protein structures. Walnut and pecan are both Juglandaceae. The immune system doesn’t distinguish between brands; it distinguishes between protein shapes.

    For parents thinking about early allergen introduction, this matters in two ways. First, it explains why certain food allergies so commonly appear together — a child allergic to cashew is very likely also reactive to pistachio, not because they encountered pistachio separately, but because the underlying proteins are nearly identical. Second, it means that early exposure to one food in a protein family may also support the immune system’s familiarity with related proteins in that same family.

    💡 An important distinction

    Cross-reactivity refers to shared protein structures between foods. It does not mean that introducing one food guarantees a specific outcome for another. What the research shows is that the protein families behind many tree nut allergies overlap significantly — and that Amuse’s formula covers the most clinically important of those families.

    The strongest cross-reactive pairings in tree nuts

    Research has identified clear patterns in which tree nuts share the highest degree of protein overlap. Two pairs stand out above all others.

    1

    Cashew ↔ Pistachio

    Cashew and pistachio belong to the same botanical family (Anacardiaceae) and share highly similar protein structures, particularly 2S albumins and vicilins. Studies have documented co-allergy rates between 64 and 100% — in one study, every pistachio-allergic patient was also cashew-allergic. The AAAAI Food Allergy Practice Parameter recommends that patients allergic to cashew avoid pistachio as a clinical standard. Amuse includes cashew. By introducing cashew’s protein family early, your baby is also being exposed to the same proteins that define pistachio allergy.

    2

    Walnut ↔ Pecan

    Walnut and pecan are members of the Juglandaceae family and show similarly strong co-reactivity. Research from the NUT CRACKER study found that two-thirds of walnut-allergic patients were also pecan-allergic — and that every pecan-allergic patient in the study was also reactive to walnut. Like cashew and pistachio, the AAAAI guidelines recommend avoiding pecan in walnut-allergic patients. Amuse includes walnut, which means daily exposure to the Juglandaceae protein family shared with pecan.

    3

    The broader hazelnut cluster

    Beyond the two primary pairs, the Pronuts study — a multicenter European oral food challenge study — identified a broader cluster of cross-reactive tree nuts: walnut, pecan, hazelnut, and macadamia. Hazelnut also bridges a second overlapping group that includes cashew, Brazil nut, pistachio, and almond. While clinical reactivity within these broader clusters is more variable than within the primary pairs (over 50% of patients sensitized to 5–6 tree nuts were clinically allergic to only 1–2), the protein family overlap is meaningful. Walnut and cashew together span much of this broader network.

    📄

    NUT CRACKER Study (2018) — Co-Reactivity Across Tree Nuts

    Elizur et al. studied nut co-reactivity in a pediatric cohort and found the cashew/pistachio and walnut/pecan pairs to be the most clinically consistent. The study also underscored the gap between sensitization and true clinical allergy — a finding that supports the value of early introduction rather than avoidance.

    Sources: Elizur A, et al. “NUT Co Reactivity – ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) Study.” Allergy. 2018;73(3):593-601. | Brough HA, et al. “Defining Challenge-Proven Coexistent Nut and Sesame Seed Allergy.” J Allergy Clin Immunol. 2020;145(4):1231-1239. | Sampson HA, et al. “Food Allergy: A Practice Parameter Update—2014.” J Allergy Clin Immunol. 2014;134(5):1016-25.

    How Amuse’s formula maps to the research

    The six allergens in Amuse were not chosen arbitrarily. They reflect both the most clinically prevalent food allergens in childhood and the most important protein family anchors in the cross-reactivity literature. Here’s how the formula maps to what the science shows.

    Amuse Ingredient Botanical Family Cross-Reactive Partner(s) Clinical Note
    Peanut Fabaceae (legume) Tree nuts (partial), sesame (via 2S albumin) 25–50% of peanut-allergic patients are co-allergic to at least one tree nut; 81% allergy reduction with early introduction (LEAP, 2015)
    Walnut Juglandaceae Pecan (strong); hazelnut, macadamia (moderate) All pecan-allergic patients in NUT CRACKER were also walnut-allergic (2018)
    Cashew Anacardiaceae Pistachio (strong); hazelnut, Brazil nut, almond (moderate) 64–100% co-allergy rate with pistachio across studies (NUT CRACKER 2018; Pronuts 2020)
    Milk Other mammalian milks (limited overlap) One of the most prevalent infant food allergies; most children outgrow by school age
    Egg Other egg proteins (chicken, duck — limited clinical relevance in infancy) Among most common early allergens; strong evidence base for early introduction (EAT study, 2016)
    Sesame Pedaliaceae Peanut and tree nuts (via shared 2S albumin); 60.7% co-allergy with peanut/tree nut in Pronuts Now a major allergen in the U.S.; cross-reactivity with peanut via 2S albumin protein family (Dreskin et al., 2021)

    Taken together, Amuse’s two tree nuts — walnut and cashew — represent the protein anchors for the five most clinically significant tree nut allergens: walnut, pecan, cashew, pistachio, and a meaningful portion of the hazelnut protein profile. Peanut and sesame share overlapping protein families via the 2S albumin structure, meaning their inclusion together is not incidental. And milk and egg round out the formula with the two most prevalent early-childhood allergens, both of which have strong clinical trial support for early introduction.

    What this means for your baby’s early introduction routine

    The practical implication here is straightforward. When your baby receives three drops of Amuse each day, they are not being introduced to six isolated foods. They are being introduced to the protein families that underlie the most common food allergies in childhood — including several that are not explicitly listed on the label.

    This does not mean Amuse introduces every possible allergen, or that it guarantees a specific outcome for any individual food. The science of cross-reactivity is probabilistic, not deterministic. What it does mean is that the formula was built with this broader protein landscape in mind — and that consistent daily exposure to these six ingredients is a more comprehensive starting point than six individual foods might suggest.

    💡 What current guidance recommends

    NIAID guidance (Togias et al., 2017) and updated AAAAI/ACAAI recommendations support introducing common allergens early — around 4–6 months, and as early as 2 months for protein exposure via oral drops. The guidance emphasizes frequency and consistency of exposure over any single large dose. Amuse is designed around that principle: small amounts, daily, starting early.

    📄

    EAT Study (2016) — Enquiring About Tolerance

    Perkin et al. demonstrated that introducing six allergens — including peanut, egg, milk, and sesame — from as early as 3 months of age was safe and feasible in breastfed infants. The EAT study provided foundational evidence that multi-allergen early introduction does not increase risk, and that the protein families Amuse covers can be introduced together without concern.

    Source: Perkin MR et al. “Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants.” N Engl J Med. 2016;374:1733-1743.

    Common questions parents ask

    Does introducing cashew in Amuse mean my baby is being introduced to pistachio too?
    Not in a direct sense — pistachio is not in the formula. What the research shows is that cashew and pistachio share closely related protein structures because they belong to the same botanical family. Introducing cashew protein exposes the immune system to those shared protein families. This is meaningfully different from introducing pistachio directly, and we would never claim the two are equivalent. But the protein family overlap is real and well-documented, which is part of why cashew was selected for the Amuse formula.
    Why doesn’t Amuse include hazelnut, almond, or pistachio directly?
    Amuse’s formula was designed to cover the most clinically important protein anchors while remaining practical for daily use. Walnut and cashew together represent the core protein families for the five most common tree nut allergens. Adding every individual tree nut would increase formula complexity without meaningfully expanding the protein coverage — and it would make daily use harder for families. The goal was a formula that is both comprehensive and simple enough to actually use every day.
    If my baby is already showing signs of a reaction to one nut, should I still use Amuse?
    If your baby has had a reaction to any food, or if your pediatrician has flagged a concern about allergy risk, please consult with your baby’s healthcare provider before starting or continuing Amuse. Amuse is designed for healthy infants without known food allergies as part of an early introduction routine. It is not a treatment for existing allergies or sensitivities.

    Bottom Line

    Amuse introduces six allergens. But because of how proteins are shared across botanical families, those six ingredients cover the protein landscape behind a much broader set of common food allergens — including pistachio, pecan, and key portions of the hazelnut and sesame protein families. The formula was designed with this breadth in mind. Consistent daily exposure to these six ingredients is a more comprehensive starting point for early allergen introduction than the ingredient list alone suggests.

    These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your child’s healthcare provider before use.

    About Amuse

    Amuse is an early allergen introduction system developed with a board-certified pediatric allergist. Our content is written by the Amuse Care Team, guest authors, or Dr. Everist herself. Each article is reviewed by Dr. Everist to ensure it  reflects the same clinical standard as the product itself.

    Dr. Brynn Everist, MD • Board-Certified Allergist & Immunologist

    Dr. Everist is a Mayo Clinic-trained allergist specializing in pediatric food allergies and sublingual immunotherapy. As the founder of Amuse, she combines clinical expertise with lived experience as a mother of three to make early allergen introduction accessible to all families.

    Published: 

    |

    Last Updated:

    |

    Medical Review By:

    Dr. Brynn Everist, MD

    Share This Article

    Keep reading

    A month-by-month guide to allergen introduction from a board-certified allergist — what the research actually says about timing, and how to make early introduction work
    A simple, evidence-based explanation of early allergen introduction, why timing matters, and how small, consistent exposure can fit into everyday life with a baby.

    Ready to Start Early Introduction?

    Amuse makes allergen introduction simple with daily sublingual drops—
    starting as early as 2 months.